Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Robert Pilson"'
Autor:
Robert Pilson, Steven R. Smith, Louis J. Aronne, Randi Fain, Sharon Zhou, Ken Fujioka, Frank L. Greenway, W. Timothy Garvey
Publikováno v:
Obesity. 25:857-865
Objective To assess the short-term tolerability of lorcaserin alone or with two dose regimens of phentermine. Methods This was a 12-week, randomized, double-blind, pilot safety study of N = 238 nondiabetic patients with obesity or overweight with ≥
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90fa419dd6c6713626f4f1fd4614805b
https://doi.org/10.1002/oby.21811
https://doi.org/10.1002/oby.21811
Autor:
Andrea Rubbert-Roth, Mark C. Genovese, Josef S Smolen, Anthony Sebba, Juan J. Gomez-Reino, Joel M. Kremer, Majed Khraishi, Ronald F van Vollenhoven, Sarah Williams, Robert Pilson
Publikováno v:
The Journal of Rheumatology. 40:768-780
Objective.To assess the longterm safety and efficacy of tocilizumab (TCZ) in patients with moderate to severe rheumatoid arthritis (RA).Methods.Patient data were from 5 randomized controlled TCZ trials (n = 4211), their open-label extension phases (n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4d12f0434794574eba8208d095013f
https://doi.org/10.3899/jrheum.120687
https://doi.org/10.3899/jrheum.120687
Autor:
Robert Pilson, Andrew Hemmings, J Wang, Soren Germer, Joel Krasnow, Ryma Benayed, Neil Kaplowitz, Mitchell Martin, Olivia Spleiss, Janet S. Lee, Adam Platt, Michael E. Weinblatt, Andrew Kenwright
Publikováno v:
Pharmacogenetics and Genomics. 21:365-374
Tocilizumab, a monoclonal antibody to interleukin-6 receptor, was recently approved for the treatment of moderate-to-severe rheumatoid arthritis. Two patients during clinical development met laboratory, but not clinical, criteria for Hy's law with bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbf9107f75145d6a7030d0d4cae96a7
https://doi.org/10.1097/fpc.0b013e32834592fe
https://doi.org/10.1097/fpc.0b013e32834592fe
Publikováno v:
Biotherapy. 9:149-157
DLE was prepared from the minority of euglycemic CD-1 mice, previously injected with STZ, and was administered to hyperglycemic CD-1 male mice 1, 2 and 3 weeks after completion of multidose STZ. Mice treated with DLE derived from 2 x 10(7) (IX) or 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2fa564e781b2c4681aca088407d40c
https://doi.org/10.1007/bf02628673
https://doi.org/10.1007/bf02628673
Publisher Summary It has been shown that antigen-specific inducer and suppressor factors may be isolated from dialysates of leukocyte extracts (DLE) by affinity adsorption and assayed by means of the leukocyte migration inhibition (LMI) test. These o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9662bce38a1547f3c43575cdf428d421
https://doi.org/10.1016/b978-0-12-409850-3.50014-0
https://doi.org/10.1016/b978-0-12-409850-3.50014-0
Autor:
K. Acott, Katsuhiko Akashi, Michel Allaray, Philippe Allard, Ralph G.I. Ashorn, Peter Baram, J. Berger, Jean Saint Blancard, J.F. Bonissent, William Borkowsky, Patrice Brunet-Lecomte, Denis Burger, Merrill W. Chase, Jean François Constant, Hervé de Muizon, Alain Blanchard de Vaucouleurs, J. Denis, K. Dogbe, Minter H. Dopson, Dominique Dormont, S. Doumerc, C.R. Drogemuller, John M. Dwyer, A. Ederlenis, A. Faggioni, Eugenia Floyd, Xavier Foullon, H. Hugh Fudenberg, Eva Gajdošová, Allan L. Goldstein, Lynn E. Greenberg, Gérald Haguenauer, Jean Hainaut, Troels Herlin, Jean-Denis Heyraud, Mary Jane Hicks, Robert S. Holzman, Jiro Inui, Jorgen Jensen, Wayburn S. Jeter, James F. Jones, Louise Just, Eliisa Karhumäki, Robert H. Keller, Jean Kermarec, Amanullah Khan, Charles H. Kirkpatrick, Phillip Klesius, Kai J.E. Krohn, H. Sherwood Lawrence, B. Lesourd, Thianda Manzara, M.R. Marescot, Vlastimil Mayer, John E. McClure, Eva Mitrová, Martin L. Morin, R. Moulias, Rebecca T. Newell, Tohru Nishihara, Tomohiko Ohno, Yasuto Okubo, Ctirad Oravec, Gary V. Paddock, Emily E. Paulling, Jean Pellegrin, J.F. Person, Eskild A. Petersen, J. Phillips, Ch. Pilet, Robert Pilson, G. Pizza, Guy Rocquet, F. Rosenfeld, Stephen J. Rozzo, Koji Saito, Thomas E. Schindler, Michael J. Schumacher, Erkki Seppälä, E. Jane Stuart, Leonard D. Stuart, Masayoshi Tanaka, Shigenori Tanaka, Kristian Thestrup-Pedersen, Marc Thinot, M. Thiollet, Kwong Y. Tsang, Mária Valášková, Jean Pierre Valleix, A.A. Vandenbark, Heikki Vapaatalo, D.L. Venton, R. Mark Vetto, J.M. Vich, Dimitri Viza, Amanda M. Williams, Gregory B. Wilson, Hideo Yamaguchi, Hugh Zachariae
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::621e33b1350474a64435e95725a468d8
https://doi.org/10.1016/b978-0-12-409850-3.50004-8
https://doi.org/10.1016/b978-0-12-409850-3.50004-8
Publikováno v:
Pediatric Research. 18:253A-253A
Peripheral blood mononuclear cells from individuals with exquisite cell-mediated immunity (CMI) to the recall antigens PPD,Diphtheria Toxoid (DT), Tetanus Toxoid (TT), or Candida (CAN) were stimulated with that antigen for 5-7 days and then subsequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1518267acc63b6d7610227ca67accb6d
https://doi.org/10.1203/00006450-198404001-00961
https://doi.org/10.1203/00006450-198404001-00961